Home » Topics » Regulatory

Regulatory
RSS

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009

Invega Sustenna approved for acute and maintenance schizophrenia treatment

Aug. 5, 2009

FDA approves AstraZeneca and Bristol-Myers' Onglyza for type 2 diabetes

Aug. 4, 2009

Wyeth's Prevenar 13 pneumococcal vaccine approved in Chile

July 16, 2009

FDA granted marketing approval for AMAG's Feraheme in chronic kidney disease

July 1, 2009

FDA approves Allergan's Ozurdex for macular edema following retinal vein occlusion

June 22, 2009

FDA approves Novartis' monoclonal antibody Ilaris for children and adults with CAPS

June 18, 2009

FDA approves Besivance for bacterial conjunctivitis

June 2, 2009

European Commission grants marketing authorization to HRA Pharma's ellaOne

May 27, 2009